Autopsy report · NCT01871532
Low-dose Gonal-f® in Ovulation Induction
Cause of deathDrug or device supply
“Study was terminated because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 4 months before it stopped.
- 24 participants enrolled.
- Results were posted on the registry 1 year 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Sponsor type
- Industry
- Conditions
- Infertility; Monofollicular Development
- Interventions
- Gonal-f®
- Participants
- 24
- Sites
- 10
- Countries
- Ireland, United Kingdom
Trials that died the same way
- INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
“Terminated due to clinical trial material production delays” - Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
“The study terminated early because the company was longer providing the investigational product.” - Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
“Study was terminated early due to lack of experimental medication (supply issues)” - Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects
“Study was terminated early as sponsor wanted to develop an improved formulation.” - Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
“The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.